Lamotrigine Reduction Before ECT
For patients on lamotrigine 200mg who are starting ECT, the recommended approach is to gradually taper lamotrigine by 25-33% every week over 4 weeks, reducing to 150mg, then 100mg, then 50mg, before discontinuing completely. 1
Rationale for Tapering Lamotrigine Before ECT
Lamotrigine requires careful tapering before ECT for several reasons:
- Lamotrigine affects seizure threshold, which is critical for ECT efficacy
- Abrupt discontinuation increases risk of withdrawal seizures, even in patients taking it for mood disorders 1
- The brain needs time to readjust to the absence of lamotrigine's effects on voltage-sensitive sodium channels 1
Recommended Tapering Schedule
For a patient on 200mg lamotrigine:
- Week 1: Reduce to 150mg daily (25% reduction)
- Week 2: Reduce to 100mg daily (50% of original dose)
- Week 3: Reduce to 50mg daily (75% reduction)
- Week 4: Discontinue completely
This follows the American Academy of Neurology recommendation for gradual discontinuation over 4 weeks with 25-33% reductions each week 1.
Special Considerations
- Higher risk patients: Consider a more gradual 6-8 week taper with 25% reductions every 2 weeks 1
- Concurrent valproate: If the patient is also taking valproate, a more gradual taper may be necessary due to valproate's effect on lamotrigine clearance 1
- Monitoring: During tapering, closely monitor for:
- Emergence of mood symptoms
- Withdrawal symptoms
- Seizure activity
Important Precautions
- Lamotrigine typically takes 4-6 weeks to reach therapeutic effectiveness due to its required slow titration schedule 1
- The risk of serious rash with lamotrigine is approximately 1.1% and is dose-related 2
- Females are at higher risk of developing rash than males (relative risk 1.8) 2
After ECT Completion
If lamotrigine needs to be restarted after ECT:
- Follow the standard titration schedule to minimize risk of serious rash
- Start at 25mg/day and gradually increase to target dose
- Consider the original 200mg dose may need adjustment based on ECT response
This approach balances the need to optimize ECT effectiveness while minimizing risks associated with lamotrigine withdrawal and reintroduction.